Alan B. Bergman
Chief Financial Officer · 20/20 Biolabs, Inc.
Individual
- 2026
- Apr 6, 2026
- 1
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Alan B. Bergman's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Neil Kumar - $45.20M in BBIO purchases and sales in the last 12 months
- RA CAPITAL MANAGEMENT, L.P. - $43.30M in SION purchases and sales in the last 12 months
- Framework Ventures IV L.P. - $42.62M in SDEV purchases and sales in the last 12 months
- Helen Torley - $42.15M in HALO purchases and sales in the last 12 months
- Eric M. Dube - $41.35M in TVTX purchases and sales in the last 12 months
- Jesse J. Geiger - $41.11M in MEDP purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Alan B. Bergman?
Alan B. Bergman is a corporate insider, tracked as Chief Financial Officer of 20/20 Biolabs, Inc. (AIDX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Alan B. Bergman last file a Form 4?
The only primary Form 4 on record is dated 6 April 2026.